These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23638650)

  • 1. Prevalence and factors associated with a prolonged QTc interval in a cohort of asymptomatic HIV-infected patients.
    Moreno T; Pérez I; Isasti G; Cabrera F; Santos J; Palacios R
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1195-8. PubMed ID: 23638650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy.
    Vallecillo G; Mojal S; Roquer A; Martinez D; Rossi P; Fonseca F; Muga R; Torrens M
    Clin Infect Dis; 2013 Oct; 57(8):1189-94. PubMed ID: 23899678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors of prolonged QTc interval in HIV-infected patients: results of the HIV-HEART study.
    Reinsch N; Buhr C; Krings P; Kaelsch H; Neuhaus K; Wieneke H; Erbel R; Neumann T;
    HIV Clin Trials; 2009; 10(4):261-8. PubMed ID: 19723613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective evaluation of the effect of atazanavir on the QTc interval and QTc dispersion in HIV-positive patients.
    Busti AJ; Tsikouris JP; Peeters MJ; Das SR; Canham RM; Abdullah SM; Margolis DM
    HIV Med; 2006 Jul; 7(5):317-22. PubMed ID: 16945077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and factors associated with erectile dysfunction in a cohort of HIV-infected patients.
    Pérez I; Moreno T; Navarro F; Santos J; Palacios R
    Int J STD AIDS; 2013 Sep; 24(9):712-5. PubMed ID: 23970586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia.
    Lu CL; Lin YH; Wong WW; Lin HH; Ho MW; Wang NC; Hsieh SM; Sheng WH; Hung CC; Chen MY
    J Microbiol Immunol Infect; 2011 Aug; 44(4):258-64. PubMed ID: 21524961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral load and CD4+ cell count as risk factors for prolonged QT interval in HIV-infected subjects: a cohort-nested case-control study in an outpatient population.
    Qaqa AY; Shaaban H; DeBari VA; Phung S; Slim J; Costeas CA; Perez G; Shamoon FE
    Cardiology; 2010; 117(2):105-11. PubMed ID: 20962525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QTc interval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs.
    Ogunmola OJ; Oladosu YO; Olamoyegun MA
    Ann Afr Med; 2015; 14(4):169-76. PubMed ID: 26470741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy.
    Pavie J; Porcher R; Torti C; Medrano J; Castagna A; Valin N; Rusconi S; Ammassari A; Ghosn J; Delaugerre C; Molina JM;
    J Antimicrob Chemother; 2011 Oct; 66(10):2372-8. PubMed ID: 21821627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QTc interval prolongation in patients with HIV and AIDS.
    Sani MU; Okeahialam BN
    J Natl Med Assoc; 2005 Dec; 97(12):1657-61. PubMed ID: 16396057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients.
    Nordin C; Kohli A; Beca S; Zaharia V; Grant T; Leider J; Marantz P
    J Electrocardiol; 2006 Apr; 39(2):199-205. PubMed ID: 16580420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolongation of the QTc interval in HIV-infected individuals compared to the general population.
    Reinsch N; Arendt M; Geisel MH; Schulze C; Holzendorf V; Warnke A; Neumann T; Brockmeyer NH; Schadendorf D; Eisele L; Erbel R; Moebus S; Jöckel KH; Esser S;
    Infection; 2017 Oct; 45(5):659-667. PubMed ID: 28776165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation.
    Patel N; Veve M; Kwon S; McNutt LA; Fish D; Miller CD
    HIV Med; 2013 Sep; 14(8):463-71. PubMed ID: 23506263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
    Landman R; Capitant C; Descamps D; Chazallon C; Peytavin G; Katlama C; Pialoux G; Bentata M; Brun-Vézinet F; Aboulker JP; Yéni P;
    J Antimicrob Chemother; 2009 Jul; 64(1):118-25. PubMed ID: 19420019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.
    Gianotti N; Galli L; Bocchiola B; Cahua T; Panzini P; Zandonà D; Salpietro S; Maillard M; Danise A; Pazzi A; Lazzarin A; Castagna A
    HIV Med; 2013 Mar; 14(3):153-60. PubMed ID: 22994659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum ferritin in HIV-positive patients is related to immune deficiency and inflammatory activity.
    López-Calderón C; Palacios R; Cobo A; Nuño E; Ruiz J; Márquez M; Santos J
    Int J STD AIDS; 2015 May; 26(6):393-7. PubMed ID: 24912540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.